GNLX Investor events

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

Published September 02, 2025 at 08:01 PM

(NASDAQ:GNLX) WESTLAKE VILLAGE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at H.C. Wainwright & Co’s Annual Global Investment Conference on Tuesday, September 9, 2025.